Literature DB >> 1969958

Kinetics and mechanism of the facile cyclization of histidyl-prolineamide to cyclo (His-Pro) in aqueous solution and the competitive influence of human plasma.

J Møss1, H Bundgaard.   

Abstract

A crucial point in the biosynthesis of cyclo (His-Pro), an endogenous and biologically active cyclic dipeptide, is the spontaneous cyclization of its precursor L-histidyl-L-prolineamide (His-ProNH2). In this study the kinetics and mechanism of the cyclization process has been investigated. His-ProNH2 was found to be converted quantitatively to cyclo(His-Pro) in aqueous solution at pH 2-10 and 37 degrees C, the rate of cyclization being maximal at pH 6-7. Buffer substances such as phosphate (pH 6-7.4) were found to catalyse the cyclization. The bell-shaped pH-rate profile observed was accounted for by assuming spontaneous and specific acid- and base-catalysed reactions of the His-ProNH2 species in which the imidazole group is protonated and the primary amino group unprotonated. The much more rapid rate of cyclization of His-ProNH2 (t1/2 of 140 min at pH 6-7 and 37 degrees C) relative to other proline-containing di- and tripeptides studied was suggested to be due to an intramolecular general acid catalytic effect by the protonated imidazole group. In the presence of human plasma enzymatic hydrolysis of His-ProNH2 competed with the cyclization and predominated greatly at 80% plasma concentration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969958     DOI: 10.1111/j.2042-7158.1990.tb05340.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Reactivity of alanylalanine diastereoisomers in neutral and acid aqueous solutions: a versatile stereoselectivity.

Authors:  Raphaël Plasson; Maika Tsuji; Masazumi Kamata; Kouichi Asakura
Journal:  Orig Life Evol Biosph       Date:  2011-05-12       Impact factor: 1.950

2.  Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

Authors:  J Møss; H Bundgaard
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

3.  Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.

Authors:  Suming Wang; Anna Blois; Tina El Rayes; Joyce F Liu; Michelle S Hirsch; Karsten Gravdal; Sangeetha Palakurthi; Diane R Bielenberg; Lars A Akslen; Ronny Drapkin; Vivek Mittal; Randolph S Watnick
Journal:  Sci Transl Med       Date:  2016-03-09       Impact factor: 17.956

4.  Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.

Authors:  Christopher R Conant; Daniel R Fuller; Tarick J El-Baba; Zhichao Zhang; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

5.  Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides.

Authors:  Luca Regazzoni; Laura Fumagalli; Angelica Artasensi; Silvia Gervasoni; Ettore Gilardoni; Angelica Mazzolari; Giancarlo Aldini; Giulio Vistoli
Journal:  Nutrients       Date:  2022-04-23       Impact factor: 6.706

6.  Preparation of Yeast Hydrolysate Enriched in Cyclo-His-Pro (CHP) by Enzymatic Hydrolysis and Evaluation of Its Functionality.

Authors:  Hyun Jung Lee; Heung Soo Son; Chung Park; Hyung Joo Suh
Journal:  Prev Nutr Food Sci       Date:  2015-12-31

Review 7.  Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.

Authors:  John A McIntosh; Mohamed S Donia; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.